Viewing Study NCT00964561


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2026-04-18 @ 5:21 PM
Study NCT ID: NCT00964561
Status: SUSPENDED
Last Update Posted: 2010-08-10
First Post: 2009-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ph1 Study of Valortim and Ciprofloxacin in Humans
Sponsor: PharmAthene, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: #0036-08-05
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Valerie Riddle, M.D., Vice President and Medical Director
Old Organization: PharmAthene, Inc.

Collaborators

Collaborators

Name Class View
None NIH View
None INDUSTRY View
None INDUSTRY View
None FED View